HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Edward A. Stadtmauer, MD


Tailoring Initial Treatment for Newly Diagnosed, Transplantation-Eligible Multiple Myeloma

March 15, 2010

High-dose melphalan (Alkeran) and autologous stem cell transplantation are commonly incorporated into the initial line of therapy for patients newly diagnosed with multiple myeloma.